NO
MANDATES

We invest our own money, make our own decisions, and can stay as long as it takes.
WELCOME
RISK

We know that early-stage means uncertainty, but uncertainty often results in great, life-changing investments.
TRUE
BELIEF

We commit to a shared mission and purpose, even before there’s proof.
REAL
IMPACT

We help charge the engine of change that will meaningfully improve millions of lives.
ASYMMETRIC
BETS

We champion companies solving our generation’s most important issues, that’s why we got into venture in the first place.

“With their finger on the pulse of the life science and psychedelic industries, Ambria Capital has been instrumental in Wesana’s early growth. We look forward to building our business relationship and friendship.”

DANIEL CARCILLO

CEO, Wesana Health

Investing in entrepreneurs obsessed with impacting and improving people’s lives.

Ambria Capital is on a mission to empower early-stage companies, in the mental health and technology spaces, that have the ambition and ability to transform markets and make a difference in millions of lives.

Eyes on the frontier

Psychedelics

Digital Health

Cryptocurrency

Cybersecurity

fund focus:

Psychedelics

Right now, tens of millions of people are suffering from some form of mental health condition. And the problem is growing worse. Suicide rates are spiking, drug overdoses are at an all-time high and more than half of those affected will receive no treatment. In the current paradigm of care, these numbers will only climb, and this tragedy will never end.

We can help fix it.

The overwhelming success of psychedelics in clinical trials offers people real hope. The scientific evidence is clear that psychedelics far outperform traditional antidepressants and some of these compounds are rapidly approaching regulatory approval. With momentum building and more amazing entrepreneurs emerging across the clinical, manufacturing, and commercial spaces, there is little doubt we are witnessing an awesome mental health revolution and a massive market opportunity.

Psychedelic-assisted therapies are the next major innovation in mental healthcare:

An increasing number of successful clinical trials

FDA breakthrough regulatory designations

Growing capital investment

Evolving public sentiment

We are on the cusp of something incredible. If we can help visionary entrepreneurs fulfill the promise that psychedelics hold, we’ve done our part.

Portfolio companies